RNAi Therapeutics Coming of Age: Targeting Complement Genes to Treat Rheumatoid Arthritis
Time: 3:00 pm
day: Conference Day One
Details:
- siRNAs to target the “undruggable” candidates and how these fit within the complement cascade
- Considering tissue specific targeting to ensure healthy complement activity remains
- Clinical data updated for the use of siRNA-based complement inhibitors in Rheumatoid Arthritis
